Martha Morrell Neuro Pace Inc (NPCE) insider trading activity

Martha Morrell is Chief Medical Officer of NeuroPace Inc. Currently has a direct ownership of 90,262 shares of NPCE, which is worth approximately $807,844. The most recent transaction as insider was on Feb 27, 2024, when has been sold 12,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 90.3K

0% 3M change

34.19% 12M change

Total Value Held $807,844

Martha Morrell Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 27 2024	BUY Grant, award, or other acquisition	-	12,500 Added 12.16%	90,262 Common Stock
Feb 05 2024	SELL Open market or private sale	$52,275 $15.17 p/Share	3,446 Reduced 4.24%	77,762 Common Stock
Feb 02 2024	SELL Open market or private sale	$213,135 $15.07 p/Share	14,143 Reduced 14.83%	81,208 Common Stock
Feb 01 2024	SELL Open market or private sale	$9,971 $15.04 p/Share	663 Reduced 0.69%	95,351 Common Stock
Jan 31 2024	SELL Open market or private sale	$28,998 $15.08 p/Share	1,923 Reduced 1.96%	96,014 Common Stock
Jan 30 2024	SELL Open market or private sale	$170,056 $15.1 p/Share	11,262 Reduced 10.31%	97,937 Common Stock
Jan 25 2024	SELL Open market or private sale	$15 $15.0 p/Share	1 Reduced 0.0%	109,199 Common Stock
Jan 24 2024	SELL Open market or private sale	$12,429 $15.03 p/Share	827 Reduced 0.75%	109,200 Common Stock
Dec 27 2023	SELL Open market or private sale	$134,596 $10.12 p/Share	13,300 Reduced 10.78%	110,027 Common Stock
Dec 26 2023	SELL Open market or private sale	$1,020 $10.0 p/Share	102 Reduced 0.08%	123,327 Common Stock
Dec 20 2023	SELL Open market or private sale	$27,682 $10.14 p/Share	2,730 Reduced 2.16%	123,429 Common Stock
Dec 06 2023	SELL Open market or private sale	$89,800 $8.16 p/Share	11,005 Reduced 8.02%	126,159 Common Stock
Feb 20 2023	BUY Grant, award, or other acquisition	-	80,000 Added 36.84%	137,164 Common Stock
Oct 07 2022	BUY Exercise of conversion of derivative security	$17 $0.03 p/Share	576 Added 1.0%	57,164 Common Stock
Mar 03 2022	BUY Grant, award, or other acquisition	-	46,760 Added 45.25%	56,588 Common Stock
Jun 04 2021	BUY Grant, award, or other acquisition	-	8,181 Added 45.76%	9,699 Common Stock

Martha Morrell

Chief Medical Officer

Mountain View, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NPCE shares.

Notify only if

Value

Insider Trading

Get notified when an Neuro Pace Inc insider buys or sells NPCE shares.

Notify only if

Operation

Value

Type

News

Receive news related to NeuroPace Inc

Track Activities on NPCE

Account